US Stock MarketDetailed Quotes
ABCL AbCellera Biologics
- 2.720
- +0.050+1.87%
Close Nov 21 16:00 ET
- 2.750
- +0.030+1.10%
Post 20:01 ET
803.40MMarket Cap-4459P/E (TTM)
2.770High2.610Low1.43MVolume2.660Open2.670Pre Close3.86MTurnover0.76%Turnover RatioLossP/E (Static)295.37MShares6.05552wk High0.75P/B514.77MFloat Cap2.33552wk Low--Dividend TTM189.25MShs Float71.910Historical High--Div YieldTTM5.99%Amplitude2.335Historical Low2.705Avg Price1Lot Size
AbCellera Biologics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -27,147.17%-28.88M | -250.56%-29.97M | 5.34%-41.71M | -115.82%-43.88M | -163.44%-19.61M | 99.92%-106K | -92.71%19.9M | -143.97%-44.06M | 13.40%277.36M | 284.97%30.91M |
| Net income from continuing operations | -78.63%-51.11M | -20.97%-36.93M | -1.25%-40.61M | -192.35%-146.4M | -57.73%-47.15M | -207.46%-28.61M | -349.93%-30.53M | -123.79%-40.11M | 3.29%158.52M | -149.86%-29.89M |
| Depreciation and amortization | 416.87%38.3M | 424.21%38.04M | -4.97%6.77M | -6.67%30.89M | -40.70%9.11M | 10.12%7.41M | 20.11%7.26M | 43.17%7.12M | 91.90%33.1M | 215.85%15.36M |
| Deferred tax | ---- | ---- | ---- | 192.72%1.96M | --8.31M | ---- | ---- | ---- | -4.76%-2.11M | ---- |
| Other non cash items | ---9.61M | -5,034.59%-40.82M | 146.97%1.71M | -190.57%-7.74M | ---- | ---- | -370.41%-795K | -513.85%-3.63M | 139.41%8.55M | -11.87%5.24M |
| Change In working capital | -180.04%-5.73M | -129.14%-8.04M | -17.75%-26.98M | -55.66%13.23M | -95.14%1.41M | 104.08%7.16M | -89.45%27.57M | 73.05%-22.91M | -28.43%29.83M | 130.68%28.99M |
| -Change in receivables | -76.79%-19.82M | 50.73%-15.86M | -208.16%-18.58M | -134.44%-36.66M | -115.78%-10.44M | 81.10%-11.21M | -111.65%-32.18M | 109.72%17.18M | 373.60%106.46M | 148.11%66.17M |
| -Change in payables and accrued expense | -79.46%1.39M | -94.86%1.98M | 76.74%-8.06M | -621.30%-15.1M | -166.41%-25.68M | 105.69%6.78M | 353.71%38.45M | -137.02%-34.65M | 35.31%-2.09M | -27.28%38.68M |
| -Change in other current assets | -72.89%2.48M | 73.33%2.13M | 40.54%-3.61M | 753.09%8.98M | 3,228.19%4.66M | 214.18%9.15M | -64.01%1.23M | 19.77%-6.06M | 59.33%-1.38M | -136.88%-149K |
| -Change in other working capital | 318.42%10.22M | -81.50%3.71M | 425.97%3.26M | 176.55%56.01M | 143.42%32.87M | 2,141.28%2.44M | 728.16%20.08M | -88.97%620K | -383.44%-73.16M | -616.63%-75.7M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -27,147.17%-28.88M | -250.56%-29.97M | 5.34%-41.71M | -115.82%-43.88M | -163.44%-19.61M | 99.92%-106K | -92.71%19.9M | -143.97%-44.06M | 13.40%277.36M | 284.97%30.91M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 128.92%3.7M | 251.49%52.1M | 119.99%29.91M | 37.30%-221.11M | -42.55%-24.32M | 95.47%-12.79M | -26.45%-34.39M | -467.32%-149.61M | -6.13%-352.63M | -1,385.03%-17.06M |
| Net PPE purchase and sale | 8.93%-18.52M | 26.07%-20.11M | -61.11%-24.14M | -8.90%-76.95M | -17.04%-14.43M | -62.48%-20.33M | 13.16%-27.2M | -3.37%-14.98M | -20.89%-70.66M | -30.75%-12.33M |
| Net intangibles purchase and sale | ---- | ---- | ---- | 72.00%-560K | ---- | ---- | ---- | ---- | ---2M | --0 |
| Net business purchase and sale | -101.52%-7.14M | -122.91%-4.91M | -32.18%-5.91M | 46.69%-13.69M | 41.17%-3.48M | 13.13%-3.54M | 70.05%-2.2M | 46.38%-4.47M | 38.54%-25.68M | -83.62%-5.91M |
| Net investment purchase and sale | 431.15%19.95M | 746.36%64.54M | 139.74%52.79M | 42.66%-155.22M | -1,294.13%-16.14M | 101.39%3.76M | -266.92%-9.99M | -2,064.72%-132.85M | -2.30%-270.72M | 89.77%-1.16M |
| Net other investing changes | 28.24%9.4M | 151.64%12.58M | 166.17%7.17M | 54.02%25.31M | 340.79%10.29M | 22.13%7.33M | -9.12%5M | 3.74%2.69M | -49.62%16.43M | -89.77%2.33M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 128.92%3.7M | 251.49%52.1M | 119.99%29.91M | 37.30%-221.11M | -42.55%-24.32M | 95.47%-12.79M | -26.45%-34.39M | -467.32%-149.61M | -6.13%-352.63M | -1,385.03%-17.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -52.56%3.15M | 532.70%2.65M | 718.12%2.83M | 736.12%10.36M | 978.80%3.77M | 34,994.74%6.63M | -64.28%419K | 85.37%-458K | 58.11%-1.63M | -80.97%349K |
| Net issuance payments of debt | ---- | ---- | ---- | 320.69%11.59M | ---- | ---- | ---- | ---- | -49.79%2.76M | -96.46%349K |
| Proceeds from stock option exercised by employees | -11.33%227K | 38.02%461K | 82.04%892K | ---- | ---- | --256K | --334K | --490K | ---- | ---- |
| Net other financing activities | -54.22%2.92M | 2,476.47%2.19M | 304.54%1.94M | 71.85%-1.23M | ---6.75M | 2,649.60%6.37M | -90.95%85K | 81.31%-948K | 53.24%-4.38M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -52.56%3.15M | 532.70%2.65M | 718.12%2.83M | 736.12%10.36M | 978.80%3.77M | 34,994.74%6.63M | -64.28%419K | 85.37%-458K | 58.11%-1.63M | -80.97%349K |
| Net cash flow | ||||||||||
| Beginning cash position | -15.18%175.6M | -31.52%150.86M | -61.27%160.61M | -17.26%414.65M | -50.08%199.71M | -74.67%207.04M | -61.46%220.31M | -17.26%414.65M | -15.65%501.14M | -22.72%400.09M |
| Current changes in cash | -251.95%-22.04M | 276.17%24.78M | 95.38%-8.97M | -231.15%-254.63M | -382.92%-40.17M | 98.47%-6.26M | -105.70%-14.07M | -374.52%-194.13M | 16.01%-76.89M | 188.59%14.2M |
| Effect of exchange rate changes | 134.52%367K | -105.40%-43K | -266.67%-781K | 106.14%589K | 193.41%1.07M | 87.57%-1.06M | 166.03%797K | -4.41%-213K | -573.61%-9.6M | 169.33%364K |
| End cash Position | -22.92%153.93M | -15.18%175.6M | -31.52%150.86M | -61.27%160.61M | -61.27%160.61M | -50.08%199.71M | -74.67%207.04M | -61.46%220.31M | -17.26%414.65M | -17.26%414.65M |
| Free cash flow | -131.92%-47.4M | -586.16%-50.08M | -11.52%-65.85M | -159.30%-121.38M | -286.21%-34.6M | 85.54%-20.44M | -103.02%-7.3M | -168.88%-59.05M | 9.98%204.7M | 171.08%18.58M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data